| 000 | 02714nam a22004215i 4500 | ||
|---|---|---|---|
| 999 |
_c395680 _d395680 |
||
| 001 | 395680 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230118224439.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230118s2022 sz | s |||| 0|eng d | ||
| 020 | _a9783030890742 | ||
| 024 | 7 |
_a10.1007/978-3-030-89074-2 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRC483.5.O64 _b2022 EB |
|
| 245 | 0 | 4 |
_aThe Kappa Opioid Receptor _cedited by Lee-Yuan Liu-Chen, Saadet Inan |
| 250 | _a1st edition 2022 | ||
| 264 | 1 |
_aCham _bSpringer International Publishing _c2022 |
|
| 300 |
_a1 recurso en línea (XI, 577 páginas) _b100 ilustraciones, 30 ilustraciones a color |
||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 347 |
_aarchivo de texto _bPDF |
||
| 490 | 0 |
_aHandbook of Experimental Pharmacology _x1865-0325 _v271 |
|
| 505 | 0 | _aFrom the contents. Preface.-Part I: Molecular aspects of KOR -- Part II: Preclinical research on pharmacology of KOR agonists and antagonists in animals -- Part III: KOR agonists and antagonists in clinical use and in past and present clinical trials. | |
| 520 | _aThis book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical applications (including clinical phase studies and approved for human use) of KOR compounds. It is divided up into the three parts: Molecular aspects of KOR, Preclinical research on pharmacology of KOR agonists and antagonists in animals and KOR agonists and antagonists in clinical use and in past and present clinical trials. The chapters "Biosensors monitor ligand-selective effects at kappa opioid receptors" and "The role of dynorphin and the kappa opioid receptor in schizophrenia and major depressive disorder: a translational approach" of this book are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com. | ||
| 988 | _aSpringer_BiomedLife_2022 | ||
| 650 | 7 |
_2embne _9147178 _aOpiáceos |
|
| 650 | 7 |
_2embne _9137893 _aFarmacología |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030890735 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030890759 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030890766 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi-org.ezproxy.universidadeuropea.es/10.1007/978-3-030-89074-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b01/2023 _dz _eIG _zSI |
||